496 related articles for article (PubMed ID: 18356663)
1. FDG PET for esophageal cancer complicated by sarcoidosis mimicking mediastinal and hilar lymph node metastases: two case reports.
Takanami K; Kaneta T; Yamada T; Kinomura S; Yamada S; Fukuda H; Takahashi S
Clin Nucl Med; 2008 Apr; 33(4):258-61. PubMed ID: 18356663
[TBL] [Abstract][Full Text] [Related]
2. Use of integrated FDG-PET/CT in sarcoidosis.
Krüger S; Buck AK; Mottaghy FM; Pauls S; Schelzig H; Hombach V; Reske SN
Clin Imaging; 2008; 32(4):269-73. PubMed ID: 18603181
[TBL] [Abstract][Full Text] [Related]
3. Clinical Significance of [
Feldman HA; Erasmus JJ; Zhou N; Antonoff MB; Mehran RJ; Rajaram R; Rice DC; Sepesi B; Swisher SG; Vaporciyan AA; Walsh GL; Hofstetter WL; Betancourt Cuellar SL
Ann Thorac Surg; 2022 Oct; 114(4):1183-1188. PubMed ID: 34634240
[TBL] [Abstract][Full Text] [Related]
4. F-18-fluorodeoxyglucose positron emission tomography-guided sampling of mediastinal lymph nodes in the diagnosis of cardiac sarcoidosis.
Simonen P; Lehtonen J; Kandolin R; Schildt J; Marjasuo S; Miettinen H; Airaksinen J; Vihinen T; Tuohinen S; Haataja P; Kupari M
Am J Cardiol; 2015 Nov; 116(10):1581-5. PubMed ID: 26411357
[TBL] [Abstract][Full Text] [Related]
5. [18F-FDG PET/CT for the detection of primary tumors metastasizing to lymph nodes of the neck].
Hu YY; Liang PY; Lin XP; Zhang X; Zhang WG; Fan W
Ai Zheng; 2009 Mar; 28(3):312-7. PubMed ID: 19619449
[TBL] [Abstract][Full Text] [Related]
6. A comparison of the features of fluorine-18 fluorodeoxyglucose-positron emission tomography (FDG-PET) between IgG4-related disease with bilateral hilar lymphadenopathy and sarcoidosis.
Ozawa Y; Yamamoto H; Yasuo M; Komatsu M; Ushiki A; Hamano H; Uehara T; Kawakami S; Fujita A; Fujinaga Y; Oguchi K; Kawa S; Hanaoka M
Nagoya J Med Sci; 2020 Feb; 82(1):101-111. PubMed ID: 32273638
[TBL] [Abstract][Full Text] [Related]
7. Hilar and mediastinal sarcoid-like reaction after the treatment of malignant tumors: imaging features and natural course on
Kaneko Y; Kato H; Matsuo M
Jpn J Radiol; 2019 Jan; 37(1):88-94. PubMed ID: 30324248
[TBL] [Abstract][Full Text] [Related]
8. [18F-fluorodeoxyglucose positron emission tomography (FDG-PET) negative poorly differentiated adenocarcinoma of lung with mediastinal lymph node metastases].
Takahashi G; Noriyuki T; Shimoda K; Furonaka O; Osaki N; Shioya S; Yonehara S; Miyata Y
Kyobu Geka; 2010 Dec; 63(13):1145-50. PubMed ID: 21174665
[TBL] [Abstract][Full Text] [Related]
9. Lymph node staging of gastric cancer using (18)F-FDG PET: a comparison study with CT.
Yun M; Lim JS; Noh SH; Hyung WJ; Cheong JH; Bong JK; Cho A; Lee JD
J Nucl Med; 2005 Oct; 46(10):1582-8. PubMed ID: 16204706
[TBL] [Abstract][Full Text] [Related]
10. Sarcoid-like reaction to malignancy on whole-body integrated (18)F-FDG PET/CT: prevalence and disease pattern.
Chowdhury FU; Sheerin F; Bradley KM; Gleeson FV
Clin Radiol; 2009 Jul; 64(7):675-81. PubMed ID: 19520211
[TBL] [Abstract][Full Text] [Related]
11. Fluorodeoxyglucose positron emission tomography (FDG-PET) is useful in the diagnosis of neurosarcoidosis.
Bolat S; Berding G; Dengler R; Stangel M; Trebst C
J Neurol Sci; 2009 Dec; 287(1-2):257-9. PubMed ID: 19755199
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic usefulness of fluorine-18-alpha-methyltyrosine positron emission tomography in combination with 18F-fluorodeoxyglucose in sarcoidosis patients.
Kaira K; Oriuchi N; Otani Y; Yanagitani N; Sunaga N; Hisada T; Ishizuka T; Endo K; Mori M
Chest; 2007 Apr; 131(4):1019-27. PubMed ID: 17426205
[TBL] [Abstract][Full Text] [Related]
13. Sarcoidlike reaction of neoplasia causing hypermetabolic thoracic adenopathy in setting of extrathoracic malignancy: report of two cases and a review of the differential diagnostic considerations.
Craun JB; Banks KP; Clemenshaw MN; Moren RW
J Nucl Med Technol; 2012 Dec; 40(4):231-5. PubMed ID: 23015478
[TBL] [Abstract][Full Text] [Related]
14. Positron emission tomography of esophageal carcinoma using (11)C-choline and (18)F-fluorodeoxyglucose: a novel method of preoperative lymph node staging.
Kobori O; Kirihara Y; Kosaka N; Hara T
Cancer; 1999 Nov; 86(9):1638-48. PubMed ID: 10547535
[TBL] [Abstract][Full Text] [Related]
15. Implication of ¹⁸F-Fluorodeoxyglucose Uptake of Affected Axillary Lymph Nodes in Cases with Breast Cancer.
Fujii T; Yajima R; Tatsuki H; Oosone K; Kuwano H
Anticancer Res; 2016 Jan; 36(1):393-7. PubMed ID: 26722071
[TBL] [Abstract][Full Text] [Related]
16. [Value of 18F-fluorodeoxyglucose-PET in the diagonosis and monitoring of pulmonary sarcoidosis: a case report].
Kaneko M; Tomioka H; Kaneda T; Kubot M; Tani S; Fujii H; Katsuyama E; Okazaki M
Nihon Kokyuki Gakkai Zasshi; 2008 Jun; 46(6):505-9. PubMed ID: 18593000
[TBL] [Abstract][Full Text] [Related]
17. Dual-time-point FDG PET for the evaluation of locoregional lymph nodes in thoracic esophageal squamous cell cancer.
Hu Q; Wang W; Zhong X; Yuan S; Fu Z; Guo H; Yu J
Eur J Radiol; 2009 May; 70(2):320-4. PubMed ID: 18602239
[TBL] [Abstract][Full Text] [Related]
18. 18F-FDG PET for mediastinal staging of lung cancer: which SUV threshold makes sense?
Hellwig D; Graeter TP; Ukena D; Groeschel A; Sybrecht GW; Schaefers HJ; Kirsch CM
J Nucl Med; 2007 Nov; 48(11):1761-6. PubMed ID: 17942814
[TBL] [Abstract][Full Text] [Related]
19. The incremental effect of positron emission tomography on diagnostic accuracy in the initial staging of esophageal carcinoma.
Kato H; Miyazaki T; Nakajima M; Takita J; Kimura H; Faried A; Sohda M; Fukai Y; Masuda N; Fukuchi M; Manda R; Ojima H; Tsukada K; Kuwano H; Oriuchi N; Endo K
Cancer; 2005 Jan; 103(1):148-56. PubMed ID: 15558794
[TBL] [Abstract][Full Text] [Related]
20. [Usefulness of fluorodeoxyglucose-positron emission tomography in a case of pleural sarcoidosis].
Hattori T; Konno S; Inomata T; Nasuhara Y; Betsuyaku T; Nishimura M
Nihon Kokyuki Gakkai Zasshi; 2009 Jul; 47(7):658-62. PubMed ID: 19637812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
